Cannabis Market Brief: U.S. Currently 2nd to China In CBD-Hemp Revenues

Palm Beach, FL – April 4, 2019 – A recent report from an independent, technology-driven analytics company specializing in the cannabis industry stated that: “… the global hemp industry reached $3.7 billion USD in retail sales in 2018, with an annual growth rate of 15% driven by continued strength in Chinese textiles, European industrials, Canadian […]

MYM Launches Updated 2019 Strategic Plan

Vancouver, BC –  April 4, 2019– MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) (“MYM” or “The Company”) is pleased to announce it has updated its 2019 strategic plan. The updated plan can be found at the Company’s website,, under the “Investors” tab. Highlights include MYM plans for global cultivation, extraction, distribution, and the creation […]

CBD Infused Product Companies Look To “Go Where The Consumers Already Are”

Palm Beach, FL – April 4, 2019 – Willie Sutton, the infamous bank robber, when he was asked why he robbed banks, answered: “… because that’s where the money is.” Today, smart marketers are “going where the money is” in the infused product markets. A recent report from respected industry researcher, Brightfield brought Sutton’s observations […]

Major Retail Stores Clearing Shelves To Carry CBD Infused Products

Palm Beach, FL – April 4, 2019 – What has seemed to be the ‘next big step’ for infused products, has finally started to happen. Everyone would gladly bet all their chips that it was only time before the big boys would jump into the retail distribution channel. Well… it was good bet, especially since […]

LeafyWell, a Subsidiary of Pyramidion Technology Group, Inc., (PYTG), is Excited to Announce Record-breaking Sales on CBD Products for the Month of March

Weston, FL – April 4, 2019 – NxGen Brands LLC, d/b/a: LeafyWell (, a wholly-owned subsidiary of Pyramidion Technology Group, Inc. (OTC Pink: PYTG), offering a variety of non-THC hemp-derived Cannabidiol (CBD) supplements, is announcing today record-breaking sales for the month of March, 2019.   Due to strong sales during March, 2019, this has enabled […]

Monoclonal Antibody Therapy Drug Market on Trajectory Towards $140 Billion

New York, NY – April 4, 2019 – Timelines on the next generation of antibody discovery may be getting shorter. Potentially incentivized by a new study on the monoclonal antibody therapy market, analysts recently projected a double-digit 10.5% CAGR by 2022, and revenues to touch $140 billion. Driving this surge is the development of new […]